Skip to content
‹ Back to IndustriesHealthcare

Exploring the Fundamentals of Validation in Life Science Manufacturing

Validation in life science manufacturing is crucial for ensuring product quality, safety, and efficacy. Regulatory changes impose stringent compliance to safeguard patient safety. The podcast episode discusses these validation processes and the challenges faced amidst evolving regulations.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Benchmark Products on MarketScale.

By Health · · Benchmark ProductsExceeding Your Benchmark PodcastGabrielle BejaranoGxp Impact Consulting
Share

Key takeaways

01

Validation ensures products meet quality, safety, and efficacy requirements.

02

Regulatory changes mandate strict compliance in life science manufacturing.

03

Lifecycle approach to validation involves commissioning, qualification, and validation.

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

In the rapidly evolving domain of life science manufacturing, validation emerges as a cornerstone to ensure that products meet stipulated requirements concerning quality, safety, and efficacy. This pivotal aspect of manufacturing comes to focus as regulatory landscapes shift, mandating stringent compliance to ensure patient safety.

Validation emerges as a cornerstone to ensure that products meet stipulated requirements concerning quality, safety, and efficacy.

In a recent episode of Exceeding Your Benchmark, a podcast by Benchmark Products, host Gabrielle Bejarano sits down with Nessiem Samuel, Co-Founder and Head of Compliance and Validation at GxP Impact Consulting, to explore the essence and intricacies of validation in life science manufacturing. The discussion spans from delineating the validation process and its criticality in ensuring product safety to the challenges faced by startups and established operations in adhering to validation norms amidst evolving regulations.

The episode underscores validation as a multi-faceted process entailing verification to ensure that products align with design specifications, guaranteeing safety and efficacy once they reach the patients. Samuel elaborates on the lifecycle approach to validation, emphasizing the importance of commissioning, qualification, and eventual validation in facility and process aspects. He shares insights on the significance of in-house process validation while suggesting the outsourcing of early commissioning tasks. Samuel also touches on strategies for effectively managing growth in life science manufacturing while ensuring validation and compliance, highlighting the role of robust planning and asset management in this endeavor.

Robust planning and asset management play a pivotal role in effectively managing growth in life science manufacturing while ensuring validation and compliance.

For those looking to deepen their understanding of validation’s pivotal role in life science manufacturing, this episode is a valuable resource. It offers expert insights into navigating the compliance and validation landscape effectively.

Video TranscriptExpand ↓

Welcome to exceeding your benchmark. A podcast brought to you by benchmark products. Tune in as we explore life science industry relevant topics, discuss industry leading practices, and dive into cutting edge solutions the industry has to offer. This is the exceeding your benchmark podcast. Hello, everyone, and welcome to another episode of seating your benchmark, a podcast brought to you by Benchmark Products. I'm most for today, Gabrielle, and I'm thrilled to be joined right now by guest, Missyne Samuel, who's actually co founder and partner at Gxp Act Consulting. Today, we'll be exploring the fundamentals of validation in life science manufacturing From start ups to large scale operations. So you're joining us to share their expertise today is Naseem. So Naseem welcome. Thank you, Gabriel. I'm the same Samuel, co founder and owner of, Gxp impact consulting. My background, I've been in a industry for over twenty seven years, working on validation, and it's all is components, whether it's a qualification, commissioning, process validation, cleaning validation, and today, I will answer questions about validation and how we can help you navigate the compliance and validation world. Absolutely. Thanks again for joining us, and I wanna ask you As an expert in the field, could you explain to our listeners, particularly those who are new to the life sciences industry, what exact evaluation means in this context and just why it's so critical to everything from startups to large scale operations. Sure. I can answer that. So validation is the process of verification to safeguard that the product meets the requirements. And the design specification, which is the quality of the product, the safety of the product, the efficacy of the product, and the design of the the product how it's being done to make sure that when it gets to the patient, it's a safe and efficacy product that they can rely on. So the safety of the product is a key and validation is the science that we use to make sure that the product is, safe for the patient. Well, sure. As the regulatory landscape, it just keeps evolving and it continues. So what are some of the key challenges that you've seen companies face to maintain a compliance with current, but also future changes that may be coming. Share some examples that you might have from your experience where changes in regulations posed, almost pretty significant roadblocks or challenges. So the the the the changes in the regulation really, is always looking for the patient safety. So if there is added measures that the regulators put on industry, is to protect the patient's safety and ensuring that the data is available to answer the question. Is the product safe or not? I see, the word validation also is used in generality. Under the umbrella of validation, there is multiple things that happen from, and we can look at a startup for a facility that's starting with, you know, just an empty shell They're gonna build clean rooms. They're gonna add equipment. They're gonna, add utilities. All these elements support the product development and the product validation at the end of its, life cycle. You know, the the idea is to make sure that the facility is adequate the equipment is adequate. All the utilities, whether it's compressed air or, WFI water, that's gonna be added to the product. How do we validate these things? How do we ensure that the product gets a pure and safe product. When your experience, what are some of the main challenges that startup space in terms of building knowledge in house but also maintaining effective validation processes. How does this compare, to the challenges faced by larger, maybe more established companies by comparison? So, in a in a startup, validation is is a a later step in the process And, but, you know, we, as a validation professionals, we're always challenged that we're the end of the line. If the project doesn't go on time, we are being tasked with, you know, compressing our timeline. You cannot make up that time again. If you already have a date in mind for a product launch, and you need your facility qualified, and you're gonna have, inspections or audits All that hinges on, you know, how validation can be performed and ensuring, again, the quality of every element that's coming together, equipment, facility, and the the environment itself even matters. So all that needs to come together at the end And for startups, sometimes the the startup is looking into well, we we are phase one. We are phase two. You really don't get into validation till you're really ready to be commercialized. And that's on the product side. But you have commissioning for the facility. You have commissioning for the utilities. Then you have validation comes in towards the latter part of the formula before ready to launch product. And if you're a phase one, start up, you have, you know, you you don't have that requirement for validation, but a lot of companies they are electing to qualify their equipment or commission their facility to ensure that the same facility that they're doing the phase one and phase two is the same facility they will transition into phase three and commercial product. And my experiences having documentation early on and having the understanding of everything you're designing for your process. Will help you in launching the product successfully again. Nassim, could you talk about the potential implications, but also the risks of utilizing outside services for validation. So how does a company decide what aspects to outsource, but also what to keep in house? That that that's a that's a really great question because through my twenty seven years, I always try to keep process validation in house. The things that you can go and outsource are the early commissioning of the building because you have only one building. Once you commission as a company, you're done with with the commissioning. You're not gonna repeat it again. Unless you're scaling it to another site or you're getting to a bigger site, you you start the process all over. So process validation, you wanna keep in house and maintain that inside. I would like to talk maybe more about when you're designing your facility, the commissioning part is for the utilities, for the HVAC system, the environment itself All these things can be outsourced. And we we try to help companies with with planning that early on having the site validation master plan explaining what's gonna be included in the project and what's gonna be done at every phase from commissioning qualification cleaning process validation, all that needs to be spelled in your site validation master plan. But I strongly, recommend that the knowledge of the product stay in house. And that's a that's a completely unbiased opinion from from doing it for many, many years in the industry. The process is to make sure that we're really the company is benefiting and the patient is benefiting. So you wanna retain that in house, the process validation piece. All the earlier work can be outsourced. Absolutely. Well, as we start wrapping up the conversation here in the scene, lastly, as life science manufacturing continues to grow and evolve What strategies or practices can companies begin to implement to effectively manage that growth, but also ensuring validation and compliance at the same time? So validation is is a is a life cycle approach, you know, from beginning of commissioning of equipment, commissioning the facility, qualifying equipment and validating some of the utilities, validating your clean rooms, validating the process. All that is a is a life cycle management approach. And regulators allow companies to build their own infrastructure, come up with their own plans. But once you create these plans, you're adhered to maintain and follow these plans. So we at Gxp also help companies with putting in the commissioning the SOPs, the qualification, the validation. We we also help companies with asset management. How do you maintain your asset for its lifetime to ensure that this asset is reliable enough to produce the product day after day? So we are always looking for the full life cycle management for this experience for the clients as their starting their own new, ventures. Alright. Miss Seem, so here we are at the end of the podcast. Are there any last thoughts you wanna share with our audience, something important that maybe we left out. I I just wanna talk about, under the validation umbrella, there is the term CQV, and CQV stands for commissioning qualification and validation. Commissioner is a term used for facility and utility commissioning qualification is used for IQ OQ and PQ, which is the qualification of equipment, and validation is used for processes like product validation, cleaning validation, and environmental monitoring for the environment in the facility. Well, that wraps up the conversation for today. Of thank you in this scene for joining us to explore the fundamentals of validation and life science manufacturing from startups to large scale operations. It was a pleasure to have you on the podcast. Gabrielle. Thank you. Of course. Well, thank you to Seemid. If you want to learn more, please visit benchmark products dot com and look for this podcast wherever it is you get your podcast at. I've been your host Gabrielle. Thanks for tuning in.

Benchmark Products

Part of this channel

Benchmark Products

ISO-certified cleanroom supplies for life science manufacturers.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

H
Health
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Medicus report projects 24% more surgery center cases and 2027 anesthesiology, GI shortages

Medicus report projects 24% more surgery center cases and 2027 anesthesiology, GI shortages

Ambulatory surgery center volumes are projected to rise 24% over the next decade. Shortages in anesthesiology and gastroenterology are projected for 2027. That puts the staffing gap early in the growth period, so for operators planning coverage and outpatient capacity, the nearer 2027 date sets the pace.

  • 01A 24% ten-year forecast and a 9% forecast for 2023 to 2028 measure different windows; check the time frame and start year before putting either in a budget.
  • 02With about nine in ten ASCs at least partly physician-owned, a staffing gap could hit physician owners directly as clinicians and investors.

Oct 30, 2026

TheraPanacea's CEO says software, not hardware, will scale radiotherapy

TheraPanacea's CEO says software, not hardware, will scale radiotherapy

TheraPanacea CEO Nikos Paragios said at ASTRO 2026 in Boston that vendor-agnostic AI software like ART-Plan can raise radiotherapy throughput on existing machines. A February 2025 Lancet Oncology study puts the global linac shortfall at 30%, with 36 of 181 countries owning no linac, limiting how far software alone can go.

  • 01A February 2025 Lancet Oncology study found a global median Linac Shortage Index of 130, a 30% capacity shortfall, and 36 of 181 countries with no linac at all.
  • 02Bundled adaptive systems already exist: Varian’s Ethos won FDA clearance in February 2020 and RaySearch demoed automated replanning at ASTRO, but buyers still need to validate acceptability and sign-off workflows.

Oct 29, 2026

Berg Insight expects 160 million home medical monitors in care programs by 2030

Berg Insight expects 160 million home medical monitors in care programs by 2030

Prescribed connected home medical monitors are forecast to grow from 92.7 million in 2025 to 159.7 million by 2030. Fastest growth is in diabetes, remote ECG and medication compliance, spread across many suppliers. Berg and IoT Business News argue value depends on integrating data into workflows.

  • 01159.7 million prescribed home medical monitors expected by 2030, growing at 11.5 percent annually from 92.7 million in 2025.
  • 02Sleep therapy is the largest connected segment, followed by diabetes with 19.5 million connections at end of 2025, with fastest future growth in diabetes, remote ECG and medication compliance monitoring.
  • 03Clinical value increasingly depends on integrating data across devices into workflows: vendors combine hardware, software, analytics and interoperability with existing healthcare systems.

Oct 26, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Experts

H
Health

Host, Exceeding Your Benchmark Podcast

Gabrielle Bejarano is the host of the Exceeding Your Benchmark Podcast at Benchmark Products. She explores industry best practices and insights in life science manufacturing through expert interviews.

NS
Nessiem Samuel

Co-Founder and Head of Compliance and Validation

GxP Impact Consulting

Nessiem Samuel is Co-Founder and Head of Compliance and Validation at GxP Impact Consulting. He has expertise in the validation process in life science manufacturing, focusing on ensuring product safety and compliance.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512